The Potential and Action Mechanism of Polyphenols in the Treatment of Liver Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Li, Sha ^a   Tan, Hor Yue ^a   Wang, Ning ^a,b   Cheung, Fan ^a   Hong, Ming ^a,c   Feng, Yibin ^a,b  

^a THE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; PATHOLOGY;

ACTION MECHANISMS; CLINICAL STUDY; HEPATOCELLULAR CARCINOMA; INSULIN RESISTANCE; LIPID METABOLISMS; LIVER INJURIES; PHYTOCHEMICALS; THERAPEUTIC EFFECTS;

DISEASES;

MICRORNA; NATURAL PRODUCT; POLYPHENOL DERIVATIVE; PHYTOCHEMICAL; POLYPHENOL;

ALCOHOL LIVER DISEASE; CARBON TETRACHLORIDE-INDUCED LIVER INJURY; CLINICAL STUDY; DRUG MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIVER CANCER; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; REVIEW; TOXIC HEPATITIS; VIRUS HEPATITIS; DRUG EFFECT; LIVER; PHYTOTHERAPY; PROCEDURES;

DISEASES; METABOLISM; POLYPHENOLS;

HUMANS; LIVER; LIVER DISEASES; PHYTOCHEMICALS; PHYTOTHERAPY; POLYPHENOLS;

EID: 85042554915     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/8394818     Document Type: Review

References (199)

1. S. Li, H. Y. Tan, N. Wang, et al., "The role of oxidative stress and antioxidants in liver diseases, " International Journal of Molecular Sciences, vol. 16, no. 11, pp. 26087-26124, 2015.
2. S. Li, M. Hong, H. Y. Tan, N. Wang., Y. Feng, "Insights into the role and interdependence of oxidative stress and inflammation in liver diseases, " Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 4234061, 21 pages, 2016.
3. S. L. Friedman, "Mechanisms of hepatic fibrogenesis, " Gastroenterology, vol. 134, no. 6, pp. 1655-1669, 2008.
4. F. Tacke, "Targeting hepatic macrophages to treat liver diseases, " Journal of Hepatology, vol. 66, no. 6, pp. 1300-1312, 2017.
5. G. A. Michelotti, M. V. Machado., A. M. Diehl, "NAFLD, NASH and liver cancer, " Nature Reviews Gastroenterology & Hepatology, vol. 10, no. 11, pp. 656-665, 2013.
6. M. Hong, S. Li, H. Tan, N. Wang, S. W. Tsao., Y. Feng, "Current status of herbal medicines in chronic liver disease therapy: The biological effects, molecular targets and future prospects, " International Journal of Molecular Sciences, vol. 16, no. 12, pp. 28705-28745, 2015.
7. A. N. Li, S. Li, Y. J. Zhang, X. R. Xu, Y. M. Chen., H. B. Li, "Resources and biological activities of natural polyphenols, " Nutrients, vol. 6, no. 12, pp. 6020-6047, 2014.
8. R. Domitrovic and I. Potocnjak, "A comprehensive overview of hepatoprotective natural compounds: Mechanism of action and clinical perspectives, " Archives of Toxicology, vol. 90, no. 1, pp. 39-79, 2016.
9. C. Manach, A. Scalbert, C. Morand, C. Remesy., L. Jimenez, "Polyphenols: Food sources and bioavailability, " The American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 727-747, 2004.
10. Y. Zhou, Y. Li, T. Zhou, J. Zheng, S. Li., H. B. Li, "Dietary natural products for prevention and treatment of liver cancer, " Nutrients, vol. 8, no. 3, p. 156, 2016.
11. G. F. Deng, X. Lin, X. R. Xu, L. L. Gao, J. F. Xie., H. B. Li, "Antioxidant capacities and total phenolic contents of 56 vegetables, " Journal of Functional Foods, vol. 5, no. 1, pp. 260-266, 2013.
12. L. Fu, B. T. Xu, X. R. Xu, et al., "Antioxidant capacities and total phenolic contents of 62 fruits, " Food Chemistry, vol. 129, no. 2, pp. 345-350, 2011.
13. G. F. Deng, X. R. Xu, Y. J. Guo, et al., "Determination of antioxidant property and their lipophilic and hydrophilic phenolic contents in cereal grains, " Journal of Functional Foods, vol. 4, no. 4, pp. 906-914, 2012.
14. B. Shan, Y. Z. Cai, M. Sun., H. Corke, "Antioxidant capacity of 26 spice extracts and characterization of their phenolic constituents, " Journal of Agricultural and Food Chemistry, vol. 53, no. 20, pp. 7749-7759, 2005.
15. Y. J. Guo, G. F. Deng, X. R. Xu, et al., "Antioxidant capacities, phenolic compounds and polysaccharide contents of 49 edible macro-fungi, " Food & Function, vol. 3, no. 11, pp. 1195-1205, 2012.
16. L. Zeng, L. Luo, H. Li., R. Liu, "Phytochemical profiles and antioxidant activity of 27 cultivars of tea, " International Journal of Food Sciences and Nutrition, vol. 68, no. 5, pp. 525-537, 2016.
17. H. Li, K. Cheng, C. Wong, K. Fan, F. Chen., Y. Jiang, "Evaluation of antioxidant capacity and total phenolic content of different fractions of selected microalgae, " Food Chemistry, vol. 102, no. 3, pp. 771-776, 2007.
18. S. Li, S. K. Li, R. Y. Gan, F. L. Song, L. Kuang., H. B. Li, "Antioxidant capacities and total phenolic contents of infusions from 223 medicinal plants, " Industrial Crops and Products, vol. 51, pp. 289-298, 2013.
19. L. Fu, B. T. Xu, X. R. Xu, X. S. Qin, R. Y. Gan., H. B. Li, "Antioxidant capacities and total phenolic contents of 56 wild fruits from South China, " Molecules, vol. 15, no. 12, pp. 8602-8617, 2010.
20. A. N. Li, S. Li, H. B. Li, D. P. Xu, X. R. Xu., F. Chen, "Total phenolic contents and antioxidant capacities of 51 edible and wild flowers, " Journal of Functional Foods, vol. 6, pp. 319-330, 2014.
21. G. F. Deng, C. Shen, X. R. Xu, et al., "Potential of fruit wastes as natural resources of bioactive compounds, " International Journal of Molecular Sciences, vol. 13, no. 12, pp. 8308-8323, 2012.
22. G. Malaguarnera, E. Cataudella, M. Giordano, G. Nunnari, G. Chisari., M. Malaguarnera, "Toxic hepatitis in occupational exposure to solvents, " World Journal of Gastroenterology, vol. 18, no. 22, pp. 2756-2766, 2012.
23. J. Q. Ma, Z. Li, W. R. Xie, C. M. Liu., S. S. Liu, "Quercetin protects mouse liver against CCl4-induced inflammation by the TLR2/4 and MAPK/NF-B pathway, " International Immunopharmacology, vol. 28, no. 1, pp. 531-539, 2015.
24. J. Q. Ma, J. Ding, H. Zhao., C. M. Liu, "Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK/c-Jun/CYP7A1 pathway, " Basic & Clinical Pharmacology & Toxicology, vol. 115, no. 5, pp. 389-395, 2014.
25. M. C. Kang, S. M. Kang, G. Ahn, et al., "Protective effect of a marine polyphenol, dieckol against carbon tetrachlorideinduced acute liver damage in mouse, " Environmental Toxicology and Pharmacology, vol. 35, no. 3, pp. 517-523, 2013.
26. D. W. Kim, H. I. Cho, K. M. Kim, et al., "Isorhamnetin-3-O-galactoside protects against CCl4-induced hepatic injury in mice, " Biomolecules & Therapeutics, vol. 20, no. 4, pp. 406-412, 2012.
27. S. Zhang, B. Lu, X. Han, et al., "Protection of the flavonoid fraction from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice, " Food and Chemical Toxicology, vol. 55, pp. 60-69, 2013.
28. C. C. Liao, Y. J. Day, H. C. Lee, J. T. Liou, A. H. Chou., F. C. Liu, "ERK signaling pathway plays a key role in baicalin protection against acetaminophen-induced liver injury, " The American Journal of Chinese Medicine, vol. 45, no. 01, pp. 105-121, 2017.
29. H. Wu, G. Zhang, L. Huang, et al., "Hepatoprotective effect of polyphenol-enriched fraction from Folium Microcos on oxidative stress and apoptosis in acetaminophen-induced liver injury in mice, " Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 3631565, 14 pages, 2017.
30. C. H. Lee, C. Y. Kuo, C. J. Wang, et al., "A polyphenol extract of Hibiscus sabdariffa L. ameliorates acetaminophen-induced hepatic steatosis by attenuating the mitochondrial dysfunction in vivo and in vitro, " Bioscience, Biotechnology., Biochemistry, vol. 76, no. 4, pp. 646-651, 2012.
31. Z. He, X. Li, H. Chen, et al., "Nobiletin attenuates lipopolysaccharide/D-galactosamine-induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-B-mediated cytokine production, " Molecular Medicine Reports, vol. 14, no. 6, pp. 5595-5600, 2016.
32. W. Zhong, K. Qian, J. Xiong, K. Ma, A. Wang., Y. Zou, "Curcumin alleviates lipopolysaccharide induced sepsis and liver failure by suppression of oxidative stress-related inflammation via PI3K/AKT and NF-B related signaling, " Biomedicine & Pharmacotherapy, vol. 83, pp. 302-313, 2016.
33. M. Zaulet, S. E. M. Kevorkian, S. Dinescu, et al., "Protective effects of silymarin against bisphenol A-induced hepatotoxicity in mouse liver, " Experimental and Therapeutic Medicine, vol. 13, no. 3, pp. 821-828, 2017.
34. S. H. Seif El-Din, N. M. El-Lakkany, M. B. Salem, O. A. Hammam, S. Saleh., S. S. Botros, "Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factorkappa B., apoptosis, " Journal of Advanced Pharmaceutical Technology & Research, vol. 7, no. 3, pp. 99-104, 2016.
35. A. Louvet and P. Mathurin, "Alcoholic liver disease: Mechanisms of injury and targeted treatment, " Nature Reviews Gastroenterology & Hepatology, vol. 12, no. 4, pp. 231-242, 2015.
36. C. M. Hu, Q. Cao, X. W. Lv, W. M. Cheng, R. Li., J. Li, "Protective effects of total flavonoids from Litsea coreana on alcoholic fatty liver in rats associated with down-regulation adipose differentiation-related protein expression, " The American Journal of Chinese Medicine, vol. 40, no. 03, pp. 599-610, 2012.
37. Q. Sun, W. Zhang, W. Zhong, X. Sun., Z. Zhou, "Dietary fisetin supplementation protects against alcohol-induced liver injury in mice, " Alcoholism, Clinical & Experimental Research, vol. 40, no. 10, pp. 2076-2084, 2016.
38. B. K. Choi, T. W. Kim, D. R. Lee, et al., "A polymethoxy flavonoids-rich Citrus aurantium extract ameliorates ethanol-induced liver injury through modulation of AMPK and Nrf2-related signals in a binge drinking mouse model, " Phytotherapy Research, vol. 29, no. 10, pp. 1577-1584, 2015.
39. G. Liu, Y. Zhang, C. Liu, et al., "Luteolin alleviates alcoholic liver disease induced by chronic and binge ethanol feeding in mice, " The Journal of Nutrition, vol. 144, no. 7, pp. 1009-1015, 2014.
40. Z. Wang, B. Su, S. Fan, H. Fei., W. Zhao, "Protective effect of oligomeric proanthocyanidins against alcohol-induced liver steatosis and injury in mice, " Biochemical and Biophysical Research Communications, vol. 458, no. 4, pp. 757-762, 2015.
41. H. Yamashita, M. Goto, I. Matsui-Yuasa., A. Kojima-Yuasa, "Ecklonia cava polyphenol has a protective effect against ethanol-induced liver injury in a cyclic AMPdependent manner, " Marine Drugs, vol. 13, no. 6, pp. 3877-3891, 2015.
42. J. S. Londhe, T. P. A. Devasagayam, L. Y. Foo, P. Shastry., S. S. Ghaskadbi, "Geraniin and amariin, ellagitannins from Phyllanthus amarus, protect liver cells against ethanol induced cytotoxicity, " Fitoterapia, vol. 83, no. 8, pp. 1562-1568, 2012.
43. R. Yao, A. Yasuoka, A. Kamei, et al., "Nuclear receptormediated alleviation of alcoholic fatty liver by polyphenols contained in alcoholic beverages, " PLoS One, vol. 9, no. 2, article e87142, 2014.
44. S. Milic, I. Mikolasevic, L. Orlic, et al., "The role of iron and iron overload in chronic liver disease, " Medical Science Monitor, vol. 22, pp. 2144-2151, 2016.
45. Y. Ren, F. Deng, H. Zhu, W. Wan, J. Ye., B. Luo, "Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease, " Molecular Biology Reports, vol. 38, no. 2, pp. 879-886, 2011.
46. L. Zeng, W. J. Tang, J. J. Yin., B. J. Zhou, "Signal transductions and nonalcoholic fatty liver: A mini-review, " International Journal of Clinical and Experimental Medicine, vol. 7, no. 7, pp. 1624-1631, 2014.
47. B. Van De Wier, G. H. Koek, A. Bast., G. R. M. M. Haenen, "The potential of flavonoids in the treatment of non-alcoholic fatty liver disease, " Critical Reviews in Food Science and Nutrition, vol. 57, no. 4, pp. 834-855, 2017.
48. C. Luo, H. Yang, C. Tang, et al., "Kaempferol alleviates insulin resistance via hepatic IKK/NF-B signal in type 2 diabetic rats, " International Immunopharmacology, vol. 28, no. 1, pp. 744-750, 2015.
49. L. M. Jimenez-Flores, S. Lopez-Briones, M. H. Macias-Cervantes, J. Ramirez-Emiliano., V. Perez-Vazquez, "A PPAR, NF-B and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver, " Molecules, vol. 19, no. 6, pp. 8289-8302, 2014.
50. X. Wang, D. M. Zhang, T. T. Gu, et al., "Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway, " Biochemical Pharmacology, vol. 86, no. 12, pp. 1791-1804, 2013.
51. J. S. Noh, C. H. Park., T. Yokozawa, "Treatment with oligonol, a low-molecular polyphenol derived from lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid metabolism, " The British Journal of Nutrition, vol. 106, no. 07, pp. 1013-1022, 2011.
52. D. Porras, E. Nistal, S. Martínez-Flórez, et al., "Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation, " Free Radical Biology & Medicine, vol. 102, pp. 188-202, 2017.
53. Z. R. Xu, J. Y. Li, X. W. Dong, et al., "Apple polyphenols decrease atherosclerosis and hepatic steatosis in ApoE/mice through the ROS/MAPK/NF-B pathway, " Nutrients, vol. 7, no. 8, pp. 7085-7105, 2015.
54. I. Cordero-Herrera, M. A. Martin, L. Goya., S. Ramos, "Cocoa flavonoids protect hepatic cells against highglucose-induced oxidative stress: Relevance of MAPKs, " Molecular Nutrition & Food Research, vol. 59, no. 4, pp. 597-609, 2015.
55. S. Medjakovic, M. Mueller., A. Jungbauer, "Potential health-modulating effects of isoflavones and metabolites via activation of PPAR and AhR, " Nutrients, vol. 2, no. 3, pp. 241-279, 2010.
56. Y. Jia, J. Y. Kim, H. J. Jun, et al., "Cyanidin is an agonistic ligand for peroxisome proliferator-activated receptor-alpha reducing hepatic lipid, " Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, vol. 1831, no. 4, pp. 698-708, 2013.
57. C. Chang, T. F. Tzeng, S. S. Liou, Y. S. Chang., I. M. Liu, "Kaempferol regulates the lipid-profile in high-fat diet-fed rats through an increase in hepatic PPAR levels, " Planta Medica, vol. 77, no. 17, pp. 1876-1882, 2011.
58. J. Goldwasser, P. Y. Cohen, E. Yang, P. Balaguer, M. L. Yarmush., Y. Nahmias, "Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: Role of PPAR, PPAR and LXR, " PLoS One, vol. 5, no. 8, article e12399, 2010.
59. T. Goto, A. Teraminami, J. Y. Lee, et al., "Tiliroside, a glycosidic flavonoid, ameliorates obesity-Induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice, " The Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 768-776, 2012.
60. J. W. Lee, S. S. Choe, H. Jang, et al., "AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity, " Journal of Lipid Research, vol. 53, no. 7, pp. 1277-1286, 2012.
61. X. Yang, Q. Wang, Z. R. Pang, M. R. Pan., W. Zhang, "Flavonoid-enriched extract from Hippophae rhamnoides seed reduces high fat diet induced obesity, hypertriglyceridemia., hepatic triglyceride accumulation in C57BL/6 mice, " Pharmaceutical Biology, vol. 55, no. 1, pp. 1207-1214, 2017.
62. E. S. Shin, H. H. Lee, S. Y. Cho, H. W. Park, S. J. Lee., T. R. Lee, "Genistein downregulates SREBP-1 regulated gene expression by inhibiting site-1 protease expression in HepG2 cells, " The Journal of Nutrition, vol. 137, no. 5, pp. 1127-1131, 2007.
63. J. F. Liu, Y. Ma, Y. Wang, Z. Y. Du, J. K. Shen., H. L. Peng, "Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress, " Phytotherapy Research, vol. 25, no. 4, pp. 588-596, 2011.
64. C. H. Wu, M. C. Lin, H. C. Wang, M. Y. Yang, M. J. Jou., C. J. Wang, "Rutin inhibits oleic acid induced lipid accumulation via reducing lipogenesis and oxidative stress in hepatocarcinoma cells, " Journal of Food Science, vol. 76, no. 2, pp. T65-T72, 2011.
65. T. G. Ahn, G. Yang, H. M. Lee, et al., "Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone, " Biochemical Pharmacology, vol. 85, no. 10, pp. 1525-1533, 2013.
66. P. Ferre and F. Foufelle, "Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c, " Diabetes, Obesity & Metabolism, vol. 12, Supplement 2, pp. 83-92, 2010.
67. Y. J. Choi, H. R. Suh, Y. Yoon, et al., "Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase, " Archives of Pharmacal Research, vol. 37, no. 9, pp. 1169-1176, 2014.
68. Z. Li, J. Xu, P. Zheng, et al., "Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway, " International Journal of Clinical and Experimental Medicine, vol. 8, no. 10, pp. 17295-17307, 2015.
69. E. H. Jung, J. H. Lee, S. C. Kim., Y. W. Kim, "AMPK activation by liquiritigenin inhibited oxidative hepatic injury and mitochondrial dysfunction induced by nutrition deprivation as mediated with induction of farnesoid X receptor, " European Journal of Nutrition, vol. 56, no. 2, pp. 635-647, 2017.
70. Y. M. Yang, S. Y. Seo, T. H. Kim., S. G. Kim, "Decrease of microRNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid, " Hepatology, vol. 56, no. 6, pp. 2209-2220, 2012.
71. L. Baselga-Escudero, A. Pascual-Serrano, A. Ribas-Latre, et al., "Long-term supplementation with a low dose of proanthocyanidins normalized liver miR-33a and miR-122 levels in high-fat diet-induced obese rats, " Nutrition Research, vol. 35, no. 4, pp. 337-345, 2015.
72. J. Joven, E. Espinel, A. Rull, et al., "Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice, " Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1820, no. 7, pp. 894-899, 2012.
73. D. Su, R. Zhang, F. Hou, et al., "Lychee pulp phenolics ameliorate hepatic lipid accumulation by reducing miR-33 and miR-122 expression in mice fed a high-fat diet, " Food & Function, vol. 8, no. 2, pp. 808-815, 2017.
74. C. Leung, L. Rivera, J. B. Furness., P. W. Angus, "The role of the gut microbiota in NAFLD, " Nature Reviews Gastroenterology & Hepatology, vol. 13, no. 7, pp. 412-425, 2016.
75. V. J. Lavallard and P. Gual, "Autophagy and non-alcoholic fatty liver disease, " BioMed Research International, vol. 2014, Article ID 120179, 13 pages, 2014.
76. M. Parafati, A. Lascala, V. M. Morittu, et al., "Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome, " The Journal of Nutritional Biochemistry, vol. 26, no. 9, pp. 938-948, 2015.
77. M. E. Inzaugarat, E. De Matteo, P. Baz, et al., "New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans, " PLoS One, vol. 12, no. 3, article e0172900, 2017.
78. C. S. Kim, H. S. Choi, Y. Joe, H. T. Chung., R. Yu, "Induction of heme oxygenase-1 with dietary quercetin reduces obesity-induced hepatic inflammation through macrophage phenotype switching, " Nutrition Research and Practice, vol. 10, no. 6, pp. 623-628, 2016.
79. L. Wang, B. Zhang, F. Huang, B. Liu., Y. Xie, "Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance, " Journal of Lipid Research, vol. 57, no. 7, pp. 1243-1255, 2016.
80. E. Zhang, S. Yin, X. Song, L. Fan., H. Hu, "Glycycoumarin inhibits hepatocyte lipoapoptosis through activation of autophagy and inhibition of ER stress/GSK-3-mediated mitochondrial pathway, " Scientific Reports, vol. 6, no. 1, article 38138, 2016.
81. L. Méndez, S. Ciordia, M. S. Fernández, et al., "Changes in liver proteins of rats fed standard and high-fat and sucrose diets induced by fish omega-3 PUFAs and their combination with grape polyphenols according to quantitative proteomics, " The Journal of Nutritional Biochemistry, vol. 41, pp. 84-97, 2017.
82. R. Patil and G. K. Sood, "Non-alcoholic fatty liver disease and cardiovascular risk, " World Journal of Gastrointestinal Pathophysiology, vol. 8, no. 2, pp. 51-58, 2017.
83. S. M. Francque, D. van der Graaff., W. J. Kwanten, "Nonalcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications, " Journal of Hepatology, vol. 65, no. 2, pp. 425-443, 2016.
84. L. Polimeni, M. Del Ben, F. Baratta, et al., "Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis, " World Journal of Hepatology, vol. 7, no. 10, pp. 1325-1336, 2015.
85. J. Tomé-Carneiro, M. Gonzálvez, M. Larrosa, et al., "Resveratrol in primary and secondary prevention of cardiovascular disease: A dietary and clinical perspective, " Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 37-51, 2013.
86. R. Afrin, S. Arumugam, A. Rahman, et al., "Curcumin ameliorates liver damage and progression of NASH in NASH-HCC mouse model possibly by modulating HMGB1-NF-B translocation, " International Immunopharmacology, vol. 44, pp. 174-182, 2017.
87. Y. B. Zhang, L. Q. Zhan, G. Q. Li, et al., "Dimeric matrine-type alkaloids from the roots of sophora flavescens and their antihepatitis B virus activities, " The Journal of Organic Chemistry, vol. 81, no. 15, pp. 6273-6280, 2016.
88. W. Xiong, X. Ma, Y. Wu, et al., "Determine the structure of phosphorylated modification of icariin and its antiviral activity against duck hepatitis virus A, " BMC Veterinary Research, vol. 11, no. 1, p. 205, 2015.
89. M. K. Parvez, A. H. Arbab, M. S. Al-Dosari., A. J. Al-Rehaily, "Antiviral natural products against chronic hepatitis B: Recent developments, " Current Pharmaceutical Design, vol. 22, no. 3, pp. 286-293, 2016.
90. H. C. Huang, M. H. Tao, T. M. Hung, J. C. Chen, Z. J. Lin., C. Huang, " Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes, " Antiviral Research, vol. 111, pp. 100-111, 2014.
91. N. Calland, A. Albecka, S. Belouzard, et al., " Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry, " Hepatology, vol. 55, no. 3, pp. 720-729, 2012.
92. S. Ciesek, T. von Hahn, C. C. Colpitts, et al., "The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry, " Hepatology, vol. 54, no. 6, pp. 1947-1955, 2011.
93. N. Calland, M. E. Sahuc, S. Belouzard, et al., "Polyphenols inhibit hepatitis C virus entry by a new mechanism of action, " Journal of Virology, vol. 89, no. 19, pp. 10053-10063, 2015.
94. S. Liu, R. Chen., C. H. Hagedorn, "Tannic acid inhibits hepatitis C virus entry into Huh7. 5 cells, " PLoS One, vol. 10, no. 7, article e0131358, 2015.
95. A. Ahmed-Belkacem, N. Ahnou, L. Barbotte, et al., "Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase, " Gastroenterology, vol. 138, no. 3, pp. 1112-1122, 2010.
96. Y. T. Lin, Y. H. Wu, C. K. Tseng, et al., "Green tea phenolic epicatechins inhibit hepatitis C virus replication via cycloxygenase-2 and attenuate virus-Induced inflammation, " PLoS One, vol. 8, no. 1, article e54466, 2013.
97. C. Shibata, M. Ohno, M. Otsuka, et al., "The flavonoid apigenin inhibits hepatitis C virus replication by decreasing mature microRNA122 levels, " Virology, vol. 462-463, pp. 42-48, 2014.
98. M. M. Rechtman, O. Har-Noy, I. Bar-Yishay, et al., "Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1, " FEBS Letters, vol. 584, no. 11, pp. 2485-2490, 2010.
99. Y. Chen, L. Zeng, J. Yang, et al., "Anti-DHAV-1 reproduction and immuno-regulatory effects of a flavonoid prescription on duck virus hepatitis, " Pharmaceutical Biology, vol. 55, no. 1, pp. 1545-1552, 2017.
100. A. Rojas, J. A. Del Campo, S. Clement, et al., "Effect of quercetin on hepatitis C virus life cycle: From viral to host targets, " Scientific Reports, vol. 6, no. 1, article 31777, 2016.
101. A. Furuta, M. Tsubuki, M. Endoh, et al., "Identification of hydroxyanthraquinones as novel inhibitors of hepatitis C virus NS3 helicase, " International Journal of Molecular Sciences, vol. 16, no. 8, pp. 18439-18453, 2015.
102. L. Bachmetov, M. Gal-Tanamy, A. Shapira, et al., "Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity, " Journal of Viral Hepatitis, vol. 19, no. 2, pp. e81-e88, 2012.
103. C. Roh and S. K. Jo, " Epigallocatechin gallate inhibits hepatitis C virus (HCV) viral protein NS5B, " Talanta, vol. 85, no. 5, pp. 2639-2642, 2011.
104. Y. Zhao, C. A. Geng, Y. B. Ma, et al., "UFLC/MS-IT-TOF guided isolation of anti-HBV active chlorogenic acid analogues from Artemisia capillaris as a traditional Chinese herb for the treatment of hepatitis, " Journal of Ethnopharmacology, vol. 156, pp. 147-154, 2014.
105. Y. Sekine-Osajima, N. Sakamoto, M. Nakagawa, et al., "Two flavonoids extracts from Glycyrrhizae radix inhibit in vitro hepatitis C virus replication, " Hepatology Research, vol. 39, no. 1, pp. 60-69, 2009.
106. M. Adianti, C. Aoki, M. Komoto, et al., "Anti-hepatitis C virus compounds obtained from Glycyrrhiza uralensis and other Glycyrrhiza species, " Microbiology and Immunology, vol. 58, no. 3, pp. 180-187, 2014.
107. D. F. Hicks, N. Goossens, A. Blas-Garciá, et al., "Transcriptome-based repurposing of apigenin as a potential antifibrotic agent targeting hepatic stellate cells, " Scientific Reports, vol. 7, article 42563, 2017.
108. M. L. Arffa, M. A. Zapf, A. N. Kothari, et al., "Epigallocatechin-3-Gallate upregulates miR-221 to inhibit osteopontindependent hepatic fibrosis, " PLoS One, vol. 11, no. 12, article e0167435, 2016.
109. L. D. Hernández-Ortega, B. E. Alcántar-Diáz, L. A. Ruiz-Corro, et al., "Quercetin improves hepatic fibrosis reducing hepatic stellate cells and regulating pro-fibrogenic/anti-fibrogenic molecules balance, " Journal of Gastroenterology and Hepatology, vol. 27, no. 12, pp. 1865-1872, 2012.
110. J. Li, P. Liu, R. Zhang, et al., "Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats, " Journal of Ethnopharmacology, vol. 137, no. 1, pp. 714-723, 2011.
111. J. Qiu, Q. Zhou, X. Zhai, X. Jia., Y. Zhou, "Curcumin regulates delta-like homolog 1 expression in activated hepatic stellate cell, " European Journal of Pharmacology, vol. 728, pp. 9-15, 2014.
112. J. Lin and A. Chen, "Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2, " Molecular and Cellular Endocrinology, vol. 333, no. 2, pp. 160-171, 2011.
113. A. Ahmad and R. Ahmad, "Resveratrol mitigate structural changes and hepatic stellate cell activation in N'-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage, " Chemico-Biological Interactions, vol. 221, pp. 1-12, 2014.
114. Y. J. Chang, S. L. Hsu, Y. T. Liu, et al., "Gallic acid induces necroptosis via TNF-signaling pathway in activated hepatic stellate cells, " PLoS One, vol. 10, no. 3, article e0120713, 2015.
115. L. He, X. Hou, F. Fan., H. Wu, "Quercetin stimulates mitochondrial apoptosis dependent on activation of endoplasmic reticulum stress in hepatic stellate cells, " Pharmaceutical Biology, vol. 54, no. 12, pp. 3237-3243, 2016.
116. C. Balta, H. Herman, O. M. Boldura, et al., "Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-/Smad signaling pathway, " Chemico-Biological Interactions, vol. 240, pp. 94-101, 2015.
117. N. Seki, U. Toh, K. Kawaguchi, et al., "Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways, " Journal of Cellular Biochemistry, vol. 113, no. 7, pp. 2346-2355, 2012.
118. H. Shi, A. Shi, L. Dong, et al., "Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress, " Clinical Nutrition, vol. 35, no. 6, pp. 1366-1373, 2016.
119. H. Zhang, Q. Sun, T. Xu, et al., "Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-B pathways, " Molecular Medicine Reports, vol. 13, no. 1, pp. 224-230, 2016.
120. D. K. Yu, C. X. Zhang, S. S. Zhao, et al., "The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway, " Acta Pharmacologica Sinica, vol. 36, no. 4, pp. 473-482, 2015.
121. Q. Wang, R. Wen, Q. Lin, N. Wang, P. Lu., X. Zhu, "Wogonoside shows antifibrotic effects in an experimental regression model of hepatic fibrosis, " Digestive Diseases and Sciences, vol. 60, no. 11, pp. 3329-3339, 2015.
122. G. H. Heeba and M. E. Mahmoud, "Therapeutic potential of morin against liver fibrosis in rats: Modulation of oxidative stress, cytokine production and nuclear factor kappa B, " Environmental Toxicology and Pharmacology, vol. 37, no. 2, pp. 662-671, 2014.
123. H. Shi, L. Dong, J. Jiang, et al., "Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway, " Toxicology, vol. 303, pp. 107-114, 2013.
124. B. Stefanska, "Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus-insights into its mechanisms of action, " British Journal of Pharmacology, vol. 166, no. 8, pp. 2209-2211, 2012.
125. L. Wang, Z. Yue, M. Guo, et al., "Dietary flavonoid hyperoside induces apoptosis of activated human LX-2 hepatic stellate cell by suppressing canonical NF-B signaling, " BioMed Research International, vol. 2016, Article ID 1068528, 10 pages, 2016.
126. J. Li, X. Li, W. Xu, et al., "Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGF/Smad signalling pathways, " Liver International, vol. 35, no. 4, pp. 1222-1233, 2015.
127. Y. Cheng, J. Y. Mai, M. F. Wang, G. F. Chen., J. Ping, "Antifibrotic effect of total flavonoids of Astmgali Radix on dimethylnitrosamine-induced liver cirrhosis in rats, " Chinese Journal of Integrative Medicine, vol. 23, no. 1, pp. 48-54, 2017.
128. T. W. Kensler, G. S. Qian, J. G. Chen., J. D. Groopman, "Translational strategies for cancer prevention in liver, " Nature Reviews Cancer, vol. 3, no. 5, pp. 321-329, 2003.
129. M. A. Mutalib, F. Ali, F. Othman, R. Ramasamy., A. Rahmat, "Phenolics profile and anti-proliferative activity of Cyphomandra Betacea fruit in breast and liver cancer cells, " SpringerPlus, vol. 5, no. 1, p. 2105, 2016.
130. X. Lin, J. Wei, Y. Chen, et al., "Isoorientin from Gypsophila elegans induces apoptosis in liver cancer cells via mitochondrial-mediated pathway, " Journal of Ethnopharmacology, vol. 187, pp. 187-194, 2016.
131. Y. L. Hsu, M. F. Hou, E. M. Tsai., P. L. Kuo, "Tricetin, a dietary flavonoid, induces apoptosis through the reactive oxygen species/c-Jun NH2-terminal kinase pathway in human liver cancer cells, " Journal of Agricultural and Food Chemistry, vol. 58, no. 23, pp. 12547-12556, 2010.
132. Y. Zhang, W. Duan, L. Owusu, D. Wu., Y. Xin, "Epigallocatechin-3-gallate induces the apoptosis of hepatocellular carcinoma LM6 cells but not non-cancerous liver cells, " International Journal of Molecular Medicine, vol. 35, no. 1, pp. 117-124, 2015.
133. H. Ali, S. Dixit, D. Ali, et al., "Isolation and evaluation of biological efficacy of quercetol in human hepatic carcinoma cells, " Drug Design, Development and Therapy, vol. 10, pp. 155-162, 2016.
134. Y. F. Wang, T. Li, Z. H. Tang, et al., "Baicalein triggers autophagy and inhibits the protein kinase B/mammalian target of rapamycin pathway in hepatocellular carcinoma HepG2 cells, " Phytotherapy Research, vol. 29, no. 5, pp. 674-679, 2015.
135. R. R. Liang, S. Zhang, J. A. Qi, et al., "Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling, " International Journal of Oncology, vol. 41, no. 3, pp. 969-978, 2012.
136. M. Zou, N. Lu, C. Hu, et al., "Beclin 1-mediated autophagy in hepatocellular carcinoma cells: Implication in anticancer efficiency of oroxylin a via inhibition of mTOR signaling, " Cellular Signalling, vol. 24, no. 8, pp. 1722-1732, 2012.
137. M. Xu, N. Lu, Z. Sun, et al., "Activation of the unfolded protein response contributed to the selective cytotoxicity of oroxylin A in human hepatocellular carcinoma HepG2 cells, " Toxicology Letters, vol. 212, no. 2, pp. 113-125, 2012.
138. T. Nishikawa, T. Nakajima, M. Moriguchi, et al., "A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins, " Journal of Hepatology, vol. 44, no. 6, pp. 1074-1082, 2006.
139. M. Shimizu, Y. Shirakami, H. Sakai, et al., "EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells, " Cancer Letters, vol. 262, no. 1, pp. 10-18, 2008.
140. X. Shen, Y. Zhang, Y. Feng, et al., "Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway, " International Journal of Oncology, vol. 44, no. 3, pp. 791-796, 2014.
141. M. Youns and W. Abdel Halim Hegazy, "The natural flavonoid Fisetin inhibits cellular proliferation of hepatic, colorectal., pancreatic cancer cells through modulation of multiple signaling pathways, " PLoS One, vol. 12, no. 1, article e0169335, 2017.
142. H. Jiang, D. Wu, D. Xu, et al., "Eupafolin exhibits potent anti-angiogenic and antitumor activity in hepatocellular carcinoma, " International Journal of Biological Sciences, vol. 13, no. 6, pp. 701-711, 2017.
143. L. Gao, L. Wang, Z. Sun, et al., "Morusin shows potent antitumor activity for human hepatocellular carcinoma in vitro and in vivo through apoptosis induction and angiogenesis inhibition, " Drug Design, Development and Therapy, vol. 11, pp. 1789-1802, 2017.
144. V. Sivaramakrishnan and S. Niranjali Devaraj, "Morin regulates the expression of NF-B-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma, " Chemico-Biological Interactions, vol. 180, no. 3, pp. 353-359, 2009.
145. H. B. Yu, H. F. Zhang, X. Zhang, et al., "Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism, " Hepato-Gastroenterology, vol. 57, no. 102-103, pp. 1241-1246, 2010.
146. S. Sur, D. Pal, R. Roy, et al., "Tea polyphenols EGCG and TF restrict tongue and liver carcinogenesis simultaneously induced by N-nitrosodiethylamine in mice, " Toxicology and Applied Pharmacology, vol. 300, pp. 34-46, 2016.
147. S. Sur, D. Pal, S. Mandal, A. Roy., C. K. Panda, "Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways, " The Journal of Nutritional Biochemistry, vol. 27, pp. 32-42, 2016.
148. X. Song, S. Yin, E. Zhang, et al., "Glycycoumarin exerts anti-liver cancer activity by directly targeting T-LAK celloriginated protein kinase, " Oncotarget, vol. 7, no. 40, pp. 65732-65743, 2016.
149. L. Yuan, J. Wang, W. Wu, Q. Liu., X. Liu, "Effect of isoorientin on intracellular antioxidant defence mechanisms in hepatoma and liver cell lines, " Biomedicine & Pharmacotherapy, vol. 81, pp. 356-362, 2016.
150. H. Dong, W. Lin, J. Wu., T. Chen, "Flavonoids activate pregnane x receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells, " BMC Biochemistry, vol. 11, no. 1, p. 23, 2010.
151. Y. Yan, J. Li, J. Han, N. Hou, Y. Song., L. Dong, "Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases, " Anti-Cancer Drugs, vol. 26, no. 5, pp. 540-546, 2015.
152. G. Liang, A. Tang, X. Lin, et al., "Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer, " International Journal of Oncology, vol. 37, no. 1, pp. 111-123, 2010.
153. J. D. He, Z. Wang, S. P. Li, et al., "Vitexin suppresses autophagy to induce apoptosis in hepatocellular carcinoma via activation of the JNK signaling pathway, " Oncotarget, vol. 7, no. 51, pp. 84520-84532, 2016.
154. C. Chen, L. Wang, R. Wang, et al., "Phenolic contents, cellular antioxidant activity and antiproliferative capacity of different varieties of oats, " Food Chemistry, vol. 239, pp. 260-267, 2018.
155. C. Huang, Y. X. Wei, M. C. Shen, Y. H. Tu, C. C. Wang., H. C. Huang, "Chrysin, abundant in morinda citrifolia fruit water-EtOAc extracts, combined with apigenin synergistically induced apoptosis and inhibited migration in human breast and liver cancer cells, " Journal of Agricultural and Food Chemistry, vol. 64, no. 21, pp. 4235-4245, 2016.
156. Y. J. Hwang, E. J. Lee, H. R. Kim., K. A. Hwang, "Molecular mechanisms of luteolin-7-O-glucoside-induced growth inhibition on human liver cancer cells: G2/M cell cycle arrest and caspase-independent apoptotic signaling pathways, " BMB Reports, vol. 46, no. 12, pp. 611-616, 2013.
157. M. Xu, N. Lu, H. Zhang, et al., "Wogonin induced cytotoxicity in human hepatocellular carcinoma cells by activation of unfolded protein response and inactivation of AKT, " Hepatology Research, vol. 43, no. 8, pp. 890-905, 2013.
158. F. Wang, Y. H. Wang, J. J. Wang, H. L. Xu., C. M. Wang, "Eriodictyol-induced anti-cancer and apoptotic effects in human hepatocellular carcinoma cells are associated with cell cycle arrest and modulation of apoptosis-related proteins, " Bangladesh Journal of Pharmacology, vol. 11, no. 2, pp. 285-291, 2016.
159. R. Banjerdpongchai, B. Wudtiwai, P. Khaw-on, W. Rachakhom, N. Duangnil., P. Kongtawelert, "Hesperidin from citrus seed induces human hepatocellular carcinoma HepG2 cell apoptosis via both mitochondrial and death receptor pathways, " Tumour Biology, vol. 37, no. 1, pp. 227-237, 2016.
160. J. Zhang, J. Song, D. Wu, J. Wang., W. Dong, "Hesperetin induces the apoptosis of hepatocellular carcinoma cells via mitochondrial pathway mediated by the increased intracellular reactive oxygen species, ATP and calcium, " Medical Oncology, vol. 32, no. 4, p. 101, 2015.
161. W. G. Zhang, X. C. Yin, X. F. Liu, et al., "Puerarin induces hepatocellular carcinoma cell apoptosis modulated by MAPK signaling pathways in a dose-dependent manner, " Anticancer Research, vol. 37, no. 8, pp. 4425-4431, 2017.
162. H. T. Zhang, H. Luo, J. Wu, et al., "Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway, " World Journal of Gastroenterology, vol. 16, no. 27, pp. 3377-3384, 2010.
163. L. Su, X. Chen, J. Wu, et al., "Galangin inhibits proliferation of hepatocellular carcinoma cells by inducing endoplasmic reticulum stress, " Food and Chemical Toxicology, vol. 62, pp. 810-816, 2013.
164. X. Huang, T. Lian, X. Guan, et al., "Dihydromyricetin reduces TGF-via P53 activation-dependent mechanism in hepatocellular carcinoma HepG2 cells, " Protein & Peptide Letters, vol. 24, no. 5, pp. 419-424, 2017.
165. D. Wang, Q. Sun, J. Wu, et al., "A new prenylated flavonoid induces G0/G1 arrest and apoptosis through p38/JNK MAPK pathways in human hepatocellular carcinoma cells, " Scientific Reports, vol. 7, no. 1, article 5736, 2017.
166. G. Shu, J. Yang, W. Zhao, et al., "Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling, " Toxicology and Applied Pharmacology, vol. 281, no. 2, pp. 157-165, 2014.
167. Z. Wang, H. Zhang, J. Zhou, et al., "Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycle, " Cancer Chemotherapy and Pharmacology, vol. 78, no. 6, pp. 1143-1150, 2016.
168. G. Huang, B. Tang, K. Tang, et al., "Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway, " Oncology Reports, vol. 31, no. 5, pp. 2377-2384, 2014.
169. H. Chen, Y. Huang, J. Huang, L. Lin., G. Wei, "Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K/Akt/NF-B signaling pathway, " Oncology Reports, vol. 37, no. 2, pp. 865-870, 2017.
170. A. Y. Choi, J. H. Choi, K. Y. Hwang, et al., "Licochalcone a induces apoptosis through endoplasmic reticulum stress via a phospholipase C1-, Ca2+., reactive oxygen speciesdependent pathway in HepG2 human hepatocellular carcinoma cells, " Apoptosis, vol. 19, no. 4, pp. 682-697, 2014.
171. D. H. Go, Y. G. Lee, D. H. Lee, et al., "3-decylcatechol induces autophagy-mediated cell death through the IRE1/JNK/p62 in hepatocellular carcinoma cells, " Oncotarget, vol. 8, no. 35, pp. 58790-58800, 2017.
172. Y. J. Zhang, H. Xiang, J. S. Liu, D. Li, Z. Y. Fang., H. Zhang, "Study on the mechanism of AMPK signaling pathway and its effect on apoptosis of human hepatocellular carcinoma SMMC-7721 cells by curcumin, " European Review for Medical and Pharmacological Sciences, vol. 21, no. 5, pp. 1144-1150, 2017.
173. Z. Liu, B. Ren, Y. Wang, et al., "Sesamol induces human hepatocellular carcinoma cells apoptosis by impairing mitochondrial function and suppressing autophagy, " Scientific Reports, vol. 7, article 45728, 2017.
174. X. Cheng, F. Zhong, K. He, S. Sun, H. Chen., J. Zhou, "EHHM, a novel phenolic natural product from Livistona chinensis, induces autophagy-related apoptosis in hepatocellular carcinoma cells, " Oncology Letters, vol. 12, no. 5, pp. 3739-3748, 2016.
175. Y. Yan, N. Liu, N. Hou, L. Dong., J. Li, "Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo, " The Journal of Nutritional Biochemistry, vol. 46, pp. 68-73, 2017.
176. S. Jagan, G. Ramakrishnan, P. Anandakumar, S. Kamaraj., T. Devaki, "Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma, " Molecular and Cellular Biochemistry, vol. 319, no. 1-2, pp. 51-59, 2008.
177. F. Yang, J. Li, J. Zhu, D. Wang, S. Chen., X. Bai, "Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-B signaling pathway in H22 tumor-bearing mice, " European Journal of Pharmacology, vol. 754, pp. 105-114, 2015.
178. K. H. Lee, M. H. Yeh, S. T. Kao, et al., "The inhibitory effect of hesperidin on tumor cell invasiveness occurs via suppression of activator protein 1 and nuclear factor-kappaB in human hepatocellular carcinoma cells, " Toxicology Letters, vol. 194, no. 1-2, pp. 42-49, 2010.
179. M. H. Yeh, S. T. Kao, C. M. Hung, C. J. Liu, K. H. Lee., C. C. Yeh, "Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells, " Toxicology Letters, vol. 184, no. 3, pp. 204-210, 2009.
180. H. R. Yen, C. J. Liu., C. C. Yeh, "Naringenin suppresses TPA-induced tumor invasion by suppressing multiple signal transduction pathways in human hepatocellular carcinoma cells, " Chemico-Biological Interactions, vol. 235, pp. 1-9, 2015.
181. S. H. Fan, Y. Y. Wang, J. Lu, et al., "Luteoloside suppresses proliferation and metastasis of hepatocellular carcinoma cells by inhibition of NLRP3 inflammasome, " PLoS One, vol. 9, no. 2, article e89961, 2014.
182. X. Liu, S. Tian, M. Liu, L. Jian., L. Zhao, "Wogonin inhibits the proliferation and invasion., induces the apoptosis of HepG2 and Bel7402 HCC cells through NFB/Bcl-2, EGFR and EGFR downstream ERK/AKT signaling, " International Journal of Molecular Medicine, vol. 38, no. 4, pp. 1250-1256, 2016.
183. S. T. Chien, M. D. Shi, Y. C. Lee, C. C. Te., Y. W. Shih, "Galangin, a novel dietary flavonoid, attenuates metastatic feature via PKC/ERK signaling pathway in TPA-treated liver cancer HepG2 cells, " Cancer Cell International, vol. 15, no. 1, p. 15, 2015.
184. M. A. Zapf, A. N. Kothari, C. E. Weber, et al., "Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma, " Surgery, vol. 158, no. 4, pp. 1039-1048, 2015.
185. W. Dai, F. Wang, L. He, et al., "Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: Partial mediation by the transcription factor NFAT1, " Molecular Carcinogenesis, vol. 54, no. 4, pp. 301-311, 2015.
186. H. Yu, C. Pan, S. Zhao, Z. Wang, H. Zhang., W. Wu, "Resveratrol inhibits tumor necrosis factor-mediated matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells, " Biomedicine & Pharmacotherapy, vol. 62, no. 6, pp. 366-372, 2008.
187. F. Gao, G. Deng, W. Liu, K. Zhou., M. Li, "Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway, " Oncology Reports, vol. 37, no. 2, pp. 1203-1211, 2017.
188. J. Shao, Q. Meng., Y. Li, "Theaflavins suppress tumor growth and metastasis via the blockage of the STAT3 pathway in hepatocellular carcinoma, " OncoTargets and Therapy, vol. 9, pp. 4265-4275, 2016.
189. T. Pei, Q. Meng, J. Han, et al., " Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma, " Oncotarget, vol. 7, no. 28, pp. 43475-43491, 2016.
190. A. K. Maurya and M. Vinayak, "Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line, " Molecular Biology Reports, vol. 42, no. 9, pp. 1419-1429, 2015.
191. S. C. Iyer, A. Gopal., D. Halagowder, "Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma, " Molecular and Cellular Biochemistry, vol. 407, no. 1-2, pp. 223-237, 2015.
192. R. H. Hussein and F. K. Khalifa, "The protective role of ellagitannins flavonoids pretreatment against Nnitrosodiethylamine induced-hepatocellular carcinoma, " Saudi Journal of Biological Sciences, vol. 21, no. 6, pp. 589-596, 2014.
193. P. W. Zhang, F. X. Chen, D. Li, W. H. Ling., H. H. Guo, "A CONSORT-Compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease, " Medicine, vol. 94, no. 20, article e758, 2015.
194. S. Chen, X. Zhao, J. Wan, et al., "Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial, " Pharmacological Research, vol. 99, pp. 74-81, 2015.
195. R. Sakata, T. Nakamura, T. Torimura, T. Ueno., M. Sata, "Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: A double-blind placebo-controlled study, " International Journal of Molecular Medicine, vol. 32, no. 5, pp. 989-994, 2013.
196. S. Chen, X. Zhao, L. Ran, et al., "Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial, " Digestive and Liver Disease, vol. 47, no. 3, pp. 226-232, 2015.
197. S. Dash, C. Xiao, C. Morgantini, L. Szeto., G. F. Lewis, "High-dose resveratrol treatment for 2 weeks inhibits intestinal and hepatic lipoprotein production in overweight/obese men, " Arteriosclerosis, Thrombosis., Vascular Biology, vol. 33, no. 12, pp. 2895-2901, 2013.
198. V. S. Chachay, G. A. Macdonald, J. H. Martin, et al., "Resveratrol does not benefit patients with nonalcoholic fatty liver disease, " Clinical Gastroenterology and Hepatology, vol. 12, no. 12, pp. 2092-2103. e6, 2014.
199. D. Goncąlves, C. Lima, P. Ferreira, et al., "Orange juice as dietary source of antioxidants for patients with hepatitis C under antiviral therapy, " Food & Nutrition Research, vol. 61, no. 1, article 1296675, 2017.